DR REDDY’S HALTS SUPPLY OF RANITIDINE

HYDERABAD: Dr Reddy’s Laboratories Ltd on Sunday said that it is suspending supply of its drug Ranitidine worldwide as a precautionary measure, following the ongoing probe by the US

Food and Drug Administration (FDA) into the reported impurity N-nitrosodimethylamine in it at low levels. Ranitidine is an over-the-counter and prescription drug which decreases the amount of acid created by the stomach. “Dr Reddys is still evaluating potential impact of the issue. As a precautionary measure, Dr Reddys is suspending all shipments worldwide of Ranitidine products until the investigation (by the FDA) outcome is available. We have both a prescription and an over-the-counter portfolio of the product,” Dr Reddys spokesperson told PTI in an email reply.